Trial site
Hospital Universitario HM Sanchinarro
- 200running trials
- 107closed trials
The trials here
What the 314 trials at this site are about, from their registry records.
- Conditions
- Lung cancer93 trials
- Metastatic breast cancer46 trials
- Colorectal cancer35 trials
- Pancreatic cancer35 trials
- Ovarian cancer33 trials
- Gastric and oesophageal cancer29 trials
- Prostate cancer28 trials
- Head and neck cancer22 trials
- Melanoma20 trials
- Bladder cancer17 trials
- Liver and biliary tract cancer15 trials
- Childhood cancers14 trials
- and 30 more
- Phase
- Phase 3103 trials
- Phase 175 trials
- Phase 265 trials
- Phase 1/253 trials
- Phase 2/39 trials
- Phase 45 trials
- Status
- Completed99 trials
- Recruiting95 trials
- Active, not recruiting80 trials
- Not yet recruiting25 trials
- Suspended7 trials
- Terminated7 trials
- Withdrawn1 trial
- Lead sponsor
- Pfizer16 trials
- AbbVie9 trials
- Janssen Research & Development, LLC9 trials
- AstraZeneca7 trials
- Eli Lilly and Company6 trials
- and 175 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer
Recruiting
Not yet recruiting
Recruiting
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
Not yet recruiting
A Phase 2 Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Recruiting
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
Recruiting
Recruiting
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
Recruiting
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 1 study of JNJ-95437446 in participants with advanced-stage solid tumors
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Recruiting
Showing 50 of 200.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer33 recruiting
- Metastatic breast cancer18 recruiting
- Prostate cancer15 recruiting
- Ovarian cancer14 recruiting
- Colorectal cancer13 recruiting
- Pancreatic cancer13 recruiting
- Gastric and oesophageal cancer9 recruiting
- Childhood cancers8 recruiting
- Acute myeloid leukaemia6 recruiting
- Head and neck cancer6 recruiting
- Liver and biliary tract cancer6 recruiting
- Triple-negative breast cancer6 recruiting
- Endometrial cancer5 recruiting
- Multiple myeloma5 recruiting
- Diffuse large B-cell lymphoma4 recruiting
- Kidney cancer4 recruiting
- Melanoma4 recruiting
- Follicular lymphoma3 recruiting
- Mantle cell lymphoma3 recruiting
- Myelodysplastic syndromes3 recruiting
- Bladder cancer2 recruiting
- Cervical cancer2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Hodgkin lymphoma2 recruiting
- Neuroendocrine tumours2 recruiting
- Asthma1 recruiting
- Brain metastases1 recruiting
- Burkitt lymphoma1 recruiting
- Chronic myeloid leukaemia1 recruiting
- COPD1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Narcolepsy1 recruiting
- Osteoarthritis1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
A Trial to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy.
Completed
Completed
A Phase 1 Study of ATV-1601, in Patients with Advanced Cancer that have AKT1 E17K Mutations
Completed
A Phase 1/2 Study of DCC-3116 in Patients With MAPK Pathway Mutant Solid Tumors
Completed
Active, not recruiting
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced NSCLC (Substudy NSCLC)
Completed
Active, not recruiting
Active, not recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Completed
Completed
KISIMA-02 vaccine-based immunotherapy for patients with pancreatic cancer
Completed
Active, not recruiting
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Active, not recruiting
Completed
Active, not recruiting
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
Completed
Active, not recruiting
Completed
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
Completed
Completed
Completed
Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
Completed
Withdrawn
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Completed
Completed
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
Completed
Showing 50 of 107.
Site data: ClinicalTrials.govUpdated 18 Nov 2026